BMS-806 – 10 mg

Brand:
Cayman
CAS:
357263-13-9
Storage:
-20
UN-No:
Non-Hazardous - /

BMS-806 is a small molecule that inhibits the first step of HIV-1 infection by blocking the binding of host cell CD4 with viral gp120 protein.{29893} It binds the exterior envelope glycoprotein gp120 (Kd= 21.1 nM; Ki = 24.9 nM), blocking the conformational change that occurs with CD4 binding and preventing fusion of the viral and target cell membranes.{29893,29895,29896} BMS-806 is specific to HIV-1 irrespective of chemokine receptor preference, with no activity against HIV-2, SIV, or a panel of additional viruses.{29894}  

 

Available on backorder

SKU: - Category:

Description

A small molecule that inhibits the first step of HIV-1 infection by blocking the binding of host cell CD4 with viral gp120 protein (Kd = 21.1 nM; Ki = 24.9 nM)


Formal name: 1-[(2R)-4-benzoyl-2-methyl-1-piperazinyl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,2-ethanedione

Synonyms:  BMS-378806

Molecular weight: 406.4

CAS: 357263-13-9

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Antivirals|Entry/fusion Inhibitors||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS